| Effect of anaerobic growth on quinolone lethality with Escherichia coli. | |
| | |
MedLine Citation:
|
PMID: 17043118 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Quinolone activity against Escherichia coli was examined during aerobic growth, aerobic treatment with chloramphenicol, and anaerobic growth. Nalidixic acid, norfloxacin, ciprofloxacin, and PD161144 were lethal for cultures growing aerobically, and the bacteriostatic activity of each quinolone was unaffected by anaerobic growth. However, lethal activity was distinct for each quinolone with cells treated aerobically with chloramphenicol or grown anaerobically. Nalidixic acid failed to kill cells under both conditions; norfloxacin killed cells when they were grown anaerobically but not when they were treated with chloramphenicol; ciprofloxacin killed cells under both conditions but required higher concentrations than those required with cells grown aerobically; and PD161144, a C-8-methoxy fluoroquinolone, was equally lethal under all conditions. Following pretreatment with nalidixic acid, a shift to anaerobic conditions or the addition of chloramphenicol rapidly blocked further cell death. Formation of quinolone-gyrase-DNA complexes, observed as a sodium dodecyl sulfate (SDS)-dependent drop in cell lysate viscosity, occurred during aerobic and anaerobic growth and in the presence and in the absence of chloramphenicol. However, lethal chromosome fragmentation, detected as a drop in viscosity in the absence of SDS, occurred with nalidixic acid treatment only under aerobic conditions in the absence of chloramphenicol. With PD161144, chromosome fragmentation was detected when the cells were grown aerobically and anaerobically and in the presence and in the absence of chloramphenicol. Thus, all quinolones tested appear to form reversible bacteriostatic complexes containing broken DNA during aerobic growth, during anaerobic growth, and when protein synthesis is blocked; however, the ability to fragment chromosomes and to rapidly kill cells under these conditions depends on quinolone structure. |
| | |
Authors:
|
Muhammad Malik; Syed Hussain; Karl Drlica |
Related Documents
:
|
12121918 - Tetracycline rapidly reaches all the constituent cells of uropathogenic escherichia col... 21511028 - Chlamydophila pneumoniae attachment and infection in low proteoglycan expressing human ... 10379558 - High magnetic field enhances stationary phase-specific transcription activity of escher... 10692378 - Penicillin binding protein 5 affects cell diameter, contour, and morphology of escheric... 19633818 - Depletion of tubulin polymerization promoting protein family member 3 suppresses hela c... 18351018 - Serum-free medium provides a clinically relevant method to increase olfactory ensheathi... |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural Date: 2006-10-16 |
Journal Detail:
|
Title: Antimicrobial agents and chemotherapy Volume: 51 ISSN: 0066-4804 ISO Abbreviation: Antimicrob. Agents Chemother. Publication Date: 2007 Jan |
Date Detail:
|
Created Date: 2006-12-21 Completed Date: 2007-07-02 Revised Date: 2009-11-18 |
Medline Journal Info:
|
Nlm Unique ID: 0315061 Medline TA: Antimicrob Agents Chemother Country: United States |
Other Details:
|
Languages: eng Pagination: 28-34 Citation Subset: IM |
Affiliation:
|
Public Health Research Institute, 225 Warren Street, Newark, NJ 07103, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aerobiosis Anaerobiosis Anti-Infective Agents / chemistry, classification, pharmacology* Chloramphenicol / chemistry, pharmacology Ciprofloxacin / chemistry, pharmacology DNA Fragmentation / drug effects DNA Gyrase / metabolism DNA, Bacterial / genetics, metabolism DnaB Helicases / metabolism Dose-Response Relationship, Drug Drug Resistance, Bacterial Escherichia coli / drug effects*, genetics, metabolism Microbial Sensitivity Tests Models, Biological Molecular Structure Nalidixic Acid / chemistry, pharmacology Quinolones / chemistry, classification, pharmacology* |
| Grant Support | |
ID/Acronym/Agency:
|
AI063431/AI/NIAID NIH HHS; AI35277/AI/NIAID NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Infective Agents; 0/DNA, Bacterial; 0/Quinolones; 389-08-2/Nalidixic Acid; 56-75-7/Chloramphenicol; 85721-33-1/Ciprofloxacin; EC 3.1.-/DnaB Helicases; EC 5.99.1.-/DNA Gyrase |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Quinolone resistance in Helicobacter pylori isolates in Germany.
Next Document: Sublethal concentrations of the aminoglycoside amikacin interfere with cell division without affecti...